105 related articles for article (PubMed ID: 23255255)
1. Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.
Wright O; Zhang L; Liu Y; Yoshimi T; Zheng Y; Tunnacliffe A
J Pept Sci; 2013 Feb; 19(2):74-83. PubMed ID: 23255255
[TBL] [Abstract][Full Text] [Related]
2. Flow-cytometric screening of aggregation-inhibitors using a fluorescence-assisted intracellular method.
Lindberg H; Sandersjöö L; Meister SW; Uhlén M; Löfblom J; Ståhl S
Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27860405
[TBL] [Abstract][Full Text] [Related]
3. A plant cell-based system that predicts aβ42 misfolding: potential as a drug discovery tool for Alzheimer's disease.
Zhao T; Zeng Y; Kermode AR
Mol Genet Metab; 2012 Nov; 107(3):571-9. PubMed ID: 22944366
[TBL] [Abstract][Full Text] [Related]
4. Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40.
Kim W; Hecht MH
J Biol Chem; 2005 Oct; 280(41):35069-76. PubMed ID: 16079141
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.
Viayna E; Sabate R; Muñoz-Torrero D
Curr Top Med Chem; 2013; 13(15):1820-42. PubMed ID: 23931440
[TBL] [Abstract][Full Text] [Related]
6. Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.
Lee LL; Ha H; Chang YT; DeLisa MP
Protein Sci; 2009 Feb; 18(2):277-86. PubMed ID: 19177561
[TBL] [Abstract][Full Text] [Related]
7. The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide.
Ashur-Fabian O; Segal-Ruder Y; Skutelsky E; Brenneman DE; Steingart RA; Giladi E; Gozes I
Peptides; 2003 Sep; 24(9):1413-23. PubMed ID: 14706557
[TBL] [Abstract][Full Text] [Related]
8. Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
Zheng Y; Tian S; Peng X; Yang J; Fu Y; Jiao Y; Zhao J; He J; Hong T
FEBS Lett; 2016 Apr; 590(7):1028-37. PubMed ID: 26991731
[TBL] [Abstract][Full Text] [Related]
9. Strong inhibition of beta-amyloid peptide aggregation realized by two-steps evolved peptides.
Ghimire Gautam S; Komatsu M; Nishigaki K
Chem Biol Drug Des; 2015 Mar; 85(3):356-68. PubMed ID: 25082146
[TBL] [Abstract][Full Text] [Related]
10. Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide.
Mustafi SM; Garai K; Crick SL; Baban B; Frieden C
Biochem Biophys Res Commun; 2010 Jul; 397(3):509-12. PubMed ID: 20515649
[TBL] [Abstract][Full Text] [Related]
11. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors.
Villar-Piqué A; Espargaró A; Sabaté R; de Groot NS; Ventura S
Microb Cell Fact; 2012 May; 11():55. PubMed ID: 22553999
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease.
McKoy AF; Chen J; Schupbach T; Hecht MH
J Biol Chem; 2012 Nov; 287(46):38992-9000. PubMed ID: 22992731
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization.
Park SK; Pegan SD; Mesecar AD; Jungbauer LM; LaDu MJ; Liebman SW
Dis Model Mech; 2011 Nov; 4(6):822-31. PubMed ID: 21810907
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.
Richter L; Munter LM; Ness J; Hildebrand PW; Dasari M; Unterreitmeier S; Bulic B; Beyermann M; Gust R; Reif B; Weggen S; Langosch D; Multhaup G
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14597-602. PubMed ID: 20679249
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
16. Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles.
Han SH; Chang YJ; Jung ES; Kim JW; Na DL; Mook-Jung I
Int J Nanomedicine; 2010 Dec; 6():1-12. PubMed ID: 21289976
[TBL] [Abstract][Full Text] [Related]
17. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.
Wurth C; Guimard NK; Hecht MH
J Mol Biol; 2002 Jun; 319(5):1279-90. PubMed ID: 12079364
[TBL] [Abstract][Full Text] [Related]
18. Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β
Gera J; Szögi T; Bozsó Z; Fülöp L; Barrera EE; Rodriguez AM; Méndez L; Delpiccolo CML; Mata EG; Cioffi F; Broersen K; Paragi G; Enriz RD
Bioorg Chem; 2018 Dec; 81():211-221. PubMed ID: 30144634
[TBL] [Abstract][Full Text] [Related]
19. Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.
Bharadwaj PR; Verdile G; Barr RK; Gupta V; Steele JW; Lachenmayer ML; Yue Z; Ehrlich ME; Petsko G; Ju S; Ringe D; Sankovich SE; Caine JM; Macreadie IG; Gandy S; Martins RN
J Alzheimers Dis; 2012; 32(4):949-67. PubMed ID: 22903131
[TBL] [Abstract][Full Text] [Related]
20. Conversion of Abeta42 into a folded soluble native-like protein using a semi-random library of amphipathic helices.
Arslan PE; Mulligan VK; Ho S; Chakrabartty A
J Mol Biol; 2010 Mar; 396(5):1284-94. PubMed ID: 20026077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
